ArriVent BioPharma, Inc.

NasdaqGM:AVBP Stock Report

Market Cap: US$621.3m

ArriVent BioPharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bing Yao

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage45.2%
CEO tenure3yrs
CEO ownership0.7%
Management average tenureless than a year
Board average tenure1.3yrs

Recent management updates

Recent updates

ArriVent Wows Investors With Promising China-Developed Lung Cancer Treatment

Jan 29

CEO Compensation Analysis

How has Bing Yao's remuneration changed compared to ArriVent BioPharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$75m

Dec 31 2023US$1mUS$536k

-US$69m

Sep 30 2023n/an/a

-US$59m

Jun 30 2023n/an/a

-US$56m

Mar 31 2023n/an/a

-US$42m

Dec 31 2022US$1mUS$516k

-US$37m

Compensation vs Market: Bing's total compensation ($USD1.19M) is below average for companies of similar size in the US market ($USD3.37M).

Compensation vs Earnings: Bing's compensation has been consistent with company performance over the past year.


CEO

Bing Yao (58 yo)

3yrs

Tenure

US$1,185,782

Compensation

Dr. Zhengbin Yao, also known as Bing, Ph D., is the Co-Founder, Chairman, President and Chief Executive Officer of ArriVent Biopharma, Inc. and also serves as a Director since June 2021. Dr. Yao serves as...


Leadership Team

NamePositionTenureCompensationOwnership
Zhengbin Yao
Co-Founderno dataUS$1.19m0.65%
$ 4.1m
Stuart Lutzker
Co-Founderno dataUS$828.75k0.44%
$ 2.7m
Robin LaChapelle
Co-Founder & COOless than a yearUS$960.99k0.29%
$ 1.8m
Winston Kung
CFO & Treasurerless than a yearno datano data
Yang Wang
Chief Technology Officerno datano datano data
James Kastenmayer
General Counsel & Secretaryless than a yearno data0.022%
$ 137.0k
Dandan Dong
Chief Business Officerno datano datano data
Meghna Chowdary
Senior Vice President of Commercial Strategyno datano datano data

0.8yrs

Average Tenure

51.5yo

Average Age

Experienced Management: AVBP's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Zhengbin Yao
Co-Founder3yrsUS$1.19m0.65%
$ 4.1m
Stuart Lutzker
Co-Founder3yrsUS$828.75k0.44%
$ 2.7m
Carl Gordon
Director1.5yrsno datano data
James Healy
Independent Director1.3yrsno datano data
Kristine Peterson
Directorless than a yearno datano data
John Hohneker
Directorless than a yearno datano data
Christian Nolet
Independent Directorless than a yearUS$79.28kno data

1.3yrs

Average Tenure

63yo

Average Age

Experienced Board: AVBP's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.